Flock, smart-money disclosures made readable

Maze Therapeutics Inc

MAZENASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

ACQUIREDT+30
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
+16,141 sh · $168.2K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−2,593 sh · $70.1K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
−16,141 sh · $434.7K
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−31,908 sh · $862.2K
Filed 2 Oct 2026SEC Form 4view source
ACQUIREDT+30
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
+7,500 sh · $78.2K
Filed 1 Oct 2026SEC Form 4view source
REDUCEDT+30
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
−7,500 sh · $202.9K
Filed 1 Oct 2026SEC Form 4view source
REDUCEDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
−9,705 sh · $254.5K
Filed 8 Sept 2026SEC Form 4view source
REDUCEDStale
Courtney Phillips
Maze Therapeutics Inc · NASDAQ
−1,738 sh · $45.8K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
−391 sh · $10.6K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Courtney Phillips
Maze Therapeutics Inc · NASDAQ
−1,990 sh · $51.8K
Filed 4 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 35 disclosures

REDUCEDStale
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
−3,207 sh · $83.4K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−129 sh · $3.3K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−1,375 sh · $37.3K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
−59 sh · $1.5K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
−625 sh · $17.0K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
−2,800 sh · $73.9K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Courtney Phillips
Maze Therapeutics Inc · NASDAQ
−22 sh · $567
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−11,282 sh · $293.5K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
−5,130 sh · $133.4K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
−36 sh · $929
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−9,852 sh · $259.9K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
−4,481 sh · $118.2K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Courtney Phillips
Maze Therapeutics Inc · NASDAQ
−243 sh · $6.6K
Filed 4 Sept 2026SEC Form 4view source
REDUCEDStale
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−2,593 sh · $68.2K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
−31,908 sh · $838.8K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
+20,000 sh
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
−16,141 sh · $425.5K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
+12,500 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Bernstein Harold
Maze Therapeutics Inc · NASDAQ
+16,141 sh · $168.2K
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Coloma Jason V
Maze Therapeutics Inc · NASDAQ
+50,000 sh
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Courtney Phillips
Maze Therapeutics Inc · NASDAQ
+11,000 sh
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
−7,500 sh · $206.8K
Filed 31 Aug 2026SEC Form 4view source
ACQUIREDStale
Dandekar Atul
Maze Therapeutics Inc · NASDAQ
+7,500 sh · $78.2K
Filed 31 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Maze Therapeutics Inc · NASDAQ
15,845 sh · $473.0K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Maze Therapeutics Inc · NASDAQ
15,800 sh · $471.6K
Filed 31 Mar 2026SEC 13Fview source